Atul (500027) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
24 Jul, 2026Executive summary
Unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, were reviewed and approved by the Board and auditors without modification.
Appointment of Mr. Vinayak Deshpande as Additional and Independent Director effective August 1, 2026, for five years, subject to member approval.
Financial highlights
Standalone revenue from operations for Q1 FY27 was ₹1,588.60 cr, up from ₹1,304.56 cr in Q1 FY26.
Standalone net profit after tax for Q1 FY27 was ₹201.03 cr, compared to ₹97.74 cr in Q1 FY26.
Consolidated revenue from operations for Q1 FY27 was ₹1,847.95 cr, up from ₹1,478.00 cr in Q1 FY26.
Consolidated net profit after tax for Q1 FY27 was ₹253.93 cr, compared to ₹132.36 cr in Q1 FY26.
Basic and diluted EPS for Q1 FY27 were ₹68.28 (standalone) and ₹83.32 (consolidated).
Outlook and guidance
No explicit forward-looking guidance provided, but strong year-over-year growth in revenue and profit indicates positive momentum.
Latest events from Atul
- Strong revenue and profit growth, dividend proposed, and MD reappointed for five years.500027
Q4 25/26 - Q3 FY26 consolidated net profit rose to ₹163.54 crore on revenue of ₹1,573.62 crore.500027Q3 25/26
- Strong revenue and profit growth in H1 FY2025, led by core chemical segments.500027Q2 25/26
- Strong revenue and profit growth driven by robust segment performance and clean audit review.500027Q1 24/25
- Q2 FY25 saw strong revenue and profit growth, led by chemicals segments and robust margins.500027Q2 24/25
- Q3 FY25 saw higher revenue and profit year-over-year, with robust segment performance.500027Q3 24/25
- Revenue and profit rose, dividend of ₹25/share proposed, and new Secretarial Auditors appointed.500027Q4 24/25
- Consolidated revenue and profit rose year-over-year, led by strong chemical segment growth.500027Q1 25/26